Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes

Biochemical and Biophysical Research Communications

Volumn 362, Issue 1, 2007, Pages 206-211

  Mordier, Sylvie ^a   Iynedjian, Patrick B ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Akt; Fatty acid; Hepatocytes; Insulin resistance; Insulin signaling; Liver; Metformin; mTOR; Palmitate; PKB

Indexed keywords

FATTY ACID; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; PALMITIC ACID; PROTEIN KINASE B; SERINE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; INSULIN RESISTANCE; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; FATTY ACIDS; HEPATOCYTES; INSULIN RESISTANCE; LIVER; MALE; METFORMIN; OBESITY; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

MAMMALIA; RATTUS;

EID: 34548092167     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.004     Document Type: Article

References (29)

1. Soskin S., Essex H.E., Herrick J.F., and Mann F.C. The mechanism of regulation of blood sugar by the liver. Am. J. Physiol-Legacy Content 124 (1938) 558-567
2. Nordlie R.C., Foster J.D., and Lange A.J. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19 (1999) 379-406
3. Aiston S., Coghlan M.P., and Agius L. Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis. Eur. J. Biochem. 270 (2003) 2773-2781
4. Iynedjian P.B., Jotterand D., Nouspikel T., Asfari M., and Pilot P.R. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. J. Biol. Chem. 264 (1989) 21824-21829
5. Campbell P.J., Mandarino L.J., and Gerich J.E. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 37 (1988) 15-21
6. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
7. Samuel V.T., Liu Z.X., Qu X., Elder B.D., Bilz S., Befroy D., Romanelli A.J., and Shulman G.I. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279 (2004) 32345-32353
8. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann. Med. 37 (2005) 347-356
9. Cleasby M.E., Dzamko N., Hegarty B.D., Cooney G.J., Kraegen E.W., and Ye J.M. Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 53 (2004) 3258-3266
10. Ribaux P., Gjinovci A., Sadowski H.B., and Iynedjian P.B. Discrimination between signaling pathways in regulation of specific gene expression by insulin and growth hormone in hepatocytes. Endocrinology 143 (2002) 3766-3772
11. Iynedjian P.B., Roth R.A., Fleischmann M., and Gjinovci A. Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase. Biochem. J. 351 Pt. 3 (2000) 621-627
12. Fleischmann M., and Iynedjian P.B. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem. J. 349 (2000) 13-17
13. Ribaux P.G., and Iynedjian P.B. Analysis of the role of protein kinase B (cAKT) in insulin-dependent induction of glucokinase and sterol regulatory element-binding protein 1 (SREBP1) mRNAs in hepatocytes. Biochem. J. 376 (2003) 697-705
14. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S.Y., Huang Q., Qin J., and Su B. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127 (2006) 125-137
15. Avruch J., Hara K., Lin Y., Liu M., Long X., Ortiz-Vega S., and Yonezawa K. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25 (2006) 6361-6372
16. Gual P., Gremeaux T., Gonzalez T., Le Marchand-Brustel Y., and Tanti J.F. MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia 46 (2003) 1532-1542
17. Tzatsos A., and Kandror K.V. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol. Cell. Biol. 26 (2006) 63-76
18. Harrington L.S., Findlay G.M., Gray A., Tolkacheva T., Wigfield S., Rebholz H., Barnett J., Leslie N.R., Cheng S., Shepherd P.R., Gout I., Downes C.P., and Lamb R.F. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166 (2004) 213-223
19. Inoki K., Zhu T., and Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 (2003) 577-590
20. Hardie D.G. AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 185-210
21. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174
22. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., and Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
23. Khamzina L., Veilleux A., Bergeron S., and Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146 (2005) 1473-1481
24. Crozier S.J., Anthony J.C., Schworer C.M., Reiter A.K., Anthony T.G., Kimball S.R., and Jefferson L.S. Tissue-specific regulation of protein synthesis by insulin and free fatty acids. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E754-E762
25. Vander Haar E., Lee S.I., Bandhakavi S., Griffin T.J., and Kim D.H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9 (2007) 316-323
26. Findlay G.M., Yan L., Procter J., Mieulet V., and Lamb R.F. A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem. J. 403 (2007) 13-20
27. Sofer A., Lei K., Johannessen C.M., and Ellisen L.W. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 25 (2005) 5834-5845
28. Yang Q., Inoki K., Kim E., and Guan K.L. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc. Natl. Acad. Sci. USA 103 (2006) 6811-6816
29. Le Marchand-Brustel Y., Gual P., Gremeaux T., Gonzalez T., Barres R., and Tanti J.F. Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochem. Soc. Trans. 31 (2003) 1152-1156